Vaccination Effect of Interleukin-6-producing Pancreatic Cancer Cells in Nude Mice: A Model of Tumor Prevention and Treatment in Immune-compromised Patients-Reference-Cited by-同舟云学术

Vaccination Effect of Interleukin-6-producing Pancreatic Cancer Cells in Nude Mice: A Model of Tumor Prevention and Treatment in Immune-compromised Patients

Published:2001-01 Issue:1 Volume:92 Page:83-87
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Yano Tomoyuki,Ishikura Hiroshi,Kato Hiroaki,Ogawa Yayoi,Kondo Satoshi,Kato Hiroyuki,Yoshiki Takashi

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2001.tb01051.x/fullpdf

Reference15 articles.

1. , et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma;Kawano;Nature,1988

2. Interleukin (IL)-6 as a pancreas carcinoma-derived vascular permeability regulator in vitro;Omi;Pathol. Res. Pract.,1996

3. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression;Saito;Int. J. Cancer,1998

4. The role of interleukin-6 in inhibition of lung metastasis in subcutaneous tumor-bearing mice;Inoue;Oncol. Rep.,2000

5. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-γ genes;Porgador;J. Immunother.,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of an in vivo-efficacious PIM3 kinase inhibitor as a candidate anti-pancreatic cancer agent;Bioorganic & Medicinal Chemistry Letters;2015-12

2. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis;Oncology Reports;2014-04-25

3. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug;Oncology Reports;2013-01-11

4. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity;Cancer Science;2011-11-07

5. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability;International Journal of Cancer;2010